Lung neuroendocrine malignancies represent around 25% of all lung cancers, however, awareness of lung NETs remains low among thoracic specialists who are often involved in the evaluation and early treatment of these patients. Diagnosis and classification can be challenging, particularly for high and low/intermediate grade lung NET types. As for rare lung NETs, bronchial carcinoid tumors, there has been some important advances in understanding of the molecular pathogenesis and development of novel treatment options with evidence on their efficacy.
Educational aims
Participants will update their knowledge on:
- The molecular pathogenesis of PNETs
- Challenges in diagnostics and correct classification of PNET types
- Current evidence for innovative treatments in bronchial carcinoid tumours
Format
- Interactive case presentations and discussion
Topics
- Molecular pathogenesis, diagnostics and classification of the PNETs
- Innovative treatments in bronchial carcinoid tumors
Learning outcomes
Following this course, participants will be able to:
- Undertake correct assessment steps in diagnostics and classification of PNETs
- Recommend appropriate novel treatment modality in management of patients bronchial carcinoid tumours
CME credit
This webinar is accredited by the European Board for Accreditation in Pneumology (EBAP), 1 CME credit per 1-hour attendance. The CME credit will be granted upon attendance during the live webinar only (attendance of at least 60 minutes is required).
What is a webinar?
A webinar closely simulates a lecture-based teaching experience. The speaker can interact with the audience, just as in a classroom setting.
This webinar comprises of a 40-minute lecture followed by a 20-minute question-and-answer sessions. During the webinar you will be asked to share your opinion on issues related to the topic using interactive polls.
All participants will be able to hear the lecturer and see the slides throughout the presentation. As a participant you will be able to pose questions or discuss ideas with the other participants via the text chat facility and the speaker will respond to the questions via the microphone.
Login guidelines
More information will be communicated in due course.
- Please log in to the webinar 20 minutes before it is scheduled to commence. If you have any technical difficulties whilst trying to log in or during the session please contact e-learning@ersnet.org
- Check Central European Summer Time.
- To achieve the best quality, we recommend avoiding downloading anything from the internet during your connection to the lecture and stopping all other programmes.
- Please also ensure that your audio settings are not set to mute and adjust the volume to a comfortable level.
Diseases / methods
- Thoracic oncology
- Cell and molecular biology
- Imaging
- Surgery
Target audience
- Thoracic oncologist
- Thoracic surgeons
- Pulmonologists
- Radiologists
- Clinician Physicians in Pulmonary Training
- Clinical researchers
- Scientists (basic, translational)
- Medical Students